According to the global intravenous (IV) ibuprofen market report by IMARC Group, the market reached a value of US$ 6.3 Billion in 2022, and it is projected to reach a value of US$ 10.2 Billion by 2028, exhibiting a CAGR of 7.78% during 2023-2028 The global intravenous (IV) ibuprofen market size reached US$ 6.3 Billion in 2022. Looking forward, IMARC Group expects the market to...